He'll keep posting updates, so do go look, from time to time, here:
. . . .Here are the weekly IMS figures.
. . . .for the Week Ending April 4, 2008:
Vytorin -- year over year:
New: -29%
Total: -20%
Market share (of New): 8.2%
Zetia -- year over year:
New -26%
Total -19%
Market share (of New) 4.8%
Crestor -- year over year
[this is an AstraZeneca product]:
New +10%
Total +6%
Market share (of New) 9.5%
Wow. Each figure is a new record, both up and down.
H/T: PharmaKing
No comments:
Post a Comment